Literature DB >> 1729406

Glutamate decarboxylases in nonneural cells of rat testis and oviduct: differential expression of GAD65 and GAD67.

N J Tillakaratne1, M G Erlander, M W Collard, K F Greif, A J Tobin.   

Abstract

gamma-Aminobutyric acid (GABA) and its synthetic enzyme, glutamate decarboxylase (GAD), are not limited to the nervous system but are also found in nonneural tissues. The mammalian brain contains at least two forms of GAD (GAD67 and GAD65), which differ from each other in size, sequence, immunoreactivity, and their interaction with the cofactor pyridoxal 5'-phosphate (PLP). We used cDNAs and antibodies specific to GAD65 and GAD67 to study the molecular identity of GADs in peripheral tissues. We detected GAD and GAD mRNAs in rat oviduct and testis. In oviduct, the size of GAD, its response to PLP, its immunoreactivity, and its hybridization to specific RNA and DNA probes all indicate the specific expression of the GAD65 gene. In contrast, rat testis expresses the GAD67 gene. The GAD in these two reproductive tissues is not in neurons but in nonneural cells. The localization of brain GAD and GAD mRNAs in the mucosal epithelial cells of the oviduct and in spermatocytes and spermatids of the testis shows that GAD is not limited to neurons and that GABA may have functions other than neurotransmission.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1729406     DOI: 10.1111/j.1471-4159.1992.tb09763.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  19 in total

1.  Two distinct forms of the 64,000 Mr protein of the cleavage stimulation factor are expressed in mouse male germ cells.

Authors:  A M Wallace; B Dass; S E Ravnik; V Tonk; N A Jenkins; D J Gilbert; N G Copeland; C C MacDonald
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

2.  Heterogeneity of the supramammillary-hippocampal pathways: evidence for a unique GABAergic neurotransmitter phenotype and regional differences.

Authors:  Rabia Soussi; Nianhui Zhang; Siroun Tahtakran; Carolyn R Houser; Monique Esclapez
Journal:  Eur J Neurosci       Date:  2010-08-16       Impact factor: 3.386

3.  ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset.

Authors:  Fariba Vaziri-Sani; Shilpa Oak; Jared Radtke; Ke Lernmark; Kristian Lynch; Carl-D Agardh; Corrado M Cilio; Asa L Lethagen; Eva Ortqvist; Mona Landin-Olsson; Carina Törn; Christiane S Hampe
Journal:  Autoimmunity       Date:  2010-03-19       Impact factor: 2.815

Review 4.  GAD, diabetes, and Stiff-Man syndrome: some progress and more questions.

Authors:  M Solimena; M H Butler; P De Camilli
Journal:  J Endocrinol Invest       Date:  1994 Jul-Aug       Impact factor: 4.256

5.  Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase.

Authors:  S F Kash; R S Johnson; L H Tecott; J L Noebels; R D Mayfield; D Hanahan; S Baekkeskov
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

6.  Studies on autoimmunity for initiation of beta-cell destruction. X. Delayed expression of a membrane-bound islet cell-specific 38 kDa autoantigen that precedes insulitis and diabetes in the diabetes-prone BB rat.

Authors:  I Y Ko; H S Jun; G S Kim; J W Yoon
Journal:  Diabetologia       Date:  1994-05       Impact factor: 10.122

Review 7.  GABA's control of stem and cancer cell proliferation in adult neural and peripheral niches.

Authors:  Stephanie Z Young; Angélique Bordey
Journal:  Physiology (Bethesda)       Date:  2009-06

8.  The gad2 promoter is a transcriptional target of estrogen receptor (ER)alpha and ER beta: a unifying hypothesis to explain diverse effects of estradiol.

Authors:  Edward D Hudgens; Lan Ji; Clifford D Carpenter; Sandra L Petersen
Journal:  J Neurosci       Date:  2009-07-08       Impact factor: 6.167

9.  Dynamic regulation of glutamate decarboxylase 67 gene expression by alternative promoters and splicing during rat testis maturation.

Authors:  Haixiong Liu; Yunbin Zhang; Shifeng Li; Yuanchang Yan; Yiping Li
Journal:  Mol Biol Rep       Date:  2009-11-13       Impact factor: 2.316

Review 10.  GAD antibodies in neurological disorders - insights and challenges.

Authors:  Francesc Graus; Albert Saiz; Josep Dalmau
Journal:  Nat Rev Neurol       Date:  2020-05-26       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.